TMCnet News
Research and Markets: The Pharmaceutical Market: GreeceResearch and Markets (http://www.researchandmarkets.com/research/7jbfwc/the) has announced the addition of the "The Pharmaceutical Market: Greece" report to their offering. The immediate threat of a Greek default and eurozone exit was reduced as the outcome of the legislative elections in June had a much more benign outcome than many feared. An exit would have - and could still be - disastrous for drugmakers operating in the market. But even Greece staying in the monetary union means the government must continue with its austerity programme. While Germany and the rest of the EU are expected to reduce the focus on austerity and introduce some pro-growth strategies, these are unlikely to generate any upside for the pharmaceutical industry and structural reforms within Greece will be maintained. Key Topics Covered
Companies Mentioned - Abbott Laboratories - Alapis Pharma - Elpen - Genesis Pharma - GlaxoSmithKline - Kleva - Lavipharm - Merck Sharp (News - Alert) & Dohme - Novartis - Pfizer - Pharmathen - Sanofi - Vianex For more information visit http://www.researchandmarkets.com/research/7jbfwc/the View source version on businesswire.com: http://www.businesswire.com/news/home/20150522005623/en/ |